Increased plasma LIGHT levels in patients with atopic dermatitis - Kotani, H.; Masuda, K.; Tamagawa‐Mineoka, R.; Nomiyama, T.; Soga, F.; Nin, M.; Asai, J.; Kishimoto, S.; Katoh, N. (Clinical and experimental immunology, 2012)
Keywords: Adult; Allergic diseases; Analytical, structural and metabolic biochemistry; Apoptosis; Apoptosis - drug effects; Atopic dermatitis; B7-2 Antigen - genetics; B7-2 Antigen - metabolism; Bcl-2 protein; Biological and medical sciences; biomarkers; Biomarkers - blood; Caspase-3; CCL17 protein; CD86 antigen; Cell Line, Tumor; Chemokine CCL17 - blood; Dermatitis; Dermatitis, Atopic - blood; Dermatitis, Atopic - immunology; Disease Progression; Drug therapy; Eosinophils - drug effects; Eosinophils - pathology; Female; Fundamental and applied biological sciences. Psychology; glycoprotein D; Herpes simplex virus; Humans; Immunoglobulin E; Immunoglobulin E - blood; Immunopathology; Inflammatory diseases; Interleukin 1; Interleukin-1beta - genetics; Interleukin-1beta - metabolism; Leukocytes (eosinophilic); LIGHT; LIGHT protein; Lymphocytes T; Lymphotoxin; Male; Medical sciences; Middle Aged; Monocytes; Monocytes - drug effects; Monocytes - immunology; Original; Peripheral blood; Plasma; Proto-Oncogene Proteins c-bcl-2 - genetics; Proto-Oncogene Proteins c-bcl-2 - metabolism; Skin allergic diseases. Stinging insect allergies; THP‐1; Tumor necrosis factor; Tumor Necrosis Factor Ligand Superfamily Member 14 - blood; Tumor Necrosis Factor Ligand Superfamily Member 14 - pharmacology; Up-Regulation; Young Adult; Human; Allergy; Immunopathology; THP-1; Skin disease; Atopic dermatitis; LIGHT; LIGHT ligand; Biochemistry; Atopy; Blood plasma